ADVISORY/Experts Available to Discuss Ephedra Ban.Business Editors ADVISORY... --(BUSINESS WIRE) TOPIC: The U.S. Food and Drug Administration stated Tuesday Tuesday: see week. that dietary supplements Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement containing the stimulant stimulant, any substance that causes an increase in activity in various parts of the nervous system or directly increases muscle activity. Cerebral, or psychic, stimulants act on the central nervous system and provide a temporary sense of alertness and well-being as ephedra ephedra: see ephedrine. have been banned from the market, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. an article by USATODAY.com. The FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. reported ephedra has been linked to approximately ap·prox·i·mate adj. 1. Almost exact or correct: the approximate time of the accident. 2. 155 deaths and an estimated 16,000 negative reactions, including heart attacks, irregular HEIR, IRREGULAR. In Louisiana, irregular heirs are those who are neither testamentary nor legal, and who have been established by law to take the succession. See Civ. Code of Lo. art. 874. heartbeats and strokes. The FDA is expected to publish details on the ban in a few weeks. Although the ban is scheduled to take effect 60 days after the rule is published, many retailers have already pulled products containing ephedra from their shelves. EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story: -0- Philip Duterme, Ph.D. has spent more than 25 years developing and marketing health products worldwide. He currently serves as president and CEO of Himalaya USA, a natural supplement company in Houston. His expertise lies in a variety of subject areas including healthcare and scientific research, natural treatments, alternative medicine and FDA legislation. Dr. Duterme is an author and frequent speaker and lecturer for health industry organizations and educational institutions. Duterme serves as executive director for the non-profit organization PHAR (Proven Herbal Ayurvedic Remedies), which was founded to disseminate scientific material and medical information to health professionals and foster their broader use in health care. PR Contact: Lacey Liner 713-863-1622 lliner@himalayausa.com Dr. D.H. Marks, of Extant Medical Legal Consulting, is an internal medicine physician. Marks can discuss issues concerning drug safety, medication adverse effects and regulatory FDA affairs. For the last several years, Marks has devoted his efforts to analyzing drug adverse effect causation, on a specific and general level. In this process, Marks has analyzed the medical records, and in many cases examined the patients, for over 1,500 cases. 205-682-7389 Dr. Bert Spilker has written 15 standard textbooks on drug development and clinical trial methodologies, and has served in senior management roles in the pharmaceutical industry and in the Pharmaceutical Trade Association. He has several adjunct appointments as professor at the University of North Carolina (medicine, pharmacy), University of Minnesota (pharmacy), and as visiting professor at the University of Illinois (clinical pharmacology). 301-718-5150 ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue. ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion